
501 - 1000 employees
𧬠Biotechnology
π Pharmaceuticals
Biotechnology β’ Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that develops RNA interference (RNAi)-based therapeutics to silence disease-causing genes and treat intractable, often intractable, cardiometabolic and pulmonary disorders. Using a portfolio of RNA chemistries and delivery technologies, Arrowhead aims to induce rapid, deep, and durable knockdown of target genes to address conditions such as hypertriglyceridemia, dyslipidemia, cardiovascular disease, and various pulmonary diseases.
π October 30
πΊπΈ United States β Remote
π΅ $190k - $255k / year
β° Full Time
π΄ Lead
π Director
π» Ghost score 0%
Where this job comes from
Posted on Arrowhead Pharmaceuticals's careers page β, not through a job board
First seen by Remote Rocketship October 30
Still open on Arrowhead Pharmaceuticals's site. Checked 28 minutes ago.

501 - 1000 employees
𧬠Biotechnology
π Pharmaceuticals
Biotechnology β’ Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that develops RNA interference (RNAi)-based therapeutics to silence disease-causing genes and treat intractable, often intractable, cardiometabolic and pulmonary disorders. Using a portfolio of RNA chemistries and delivery technologies, Arrowhead aims to induce rapid, deep, and durable knockdown of target genes to address conditions such as hypertriglyceridemia, dyslipidemia, cardiovascular disease, and various pulmonary diseases.
β’ Serve as the pharmacometrics and clinical pharmacology lead across multiple development programs within Arrowheadβs RNAi therapeutic portfolio. β’ Lead model-informed drug development strategies, including population PK/PD analyses, exposure-response analyses, translational modeling, dose optimization, and quantitative interpretation of clinical and translational data. β’ Develop and support clinical pharmacology strategies for first-in-human studies, dose escalation and optimization, proof-of-concept studies, drug-drug interaction assessments, food effect studies, and special population evaluations. β’ Provide scientific leadership and oversight for PK/PD analyses and modeling activities conducted internally and through external CRO partners. β’ Contribute to global regulatory submissions and health authority interactions, including INDs, CTAs, NDA/BLA submissions, briefing documents, and responses to agency questions. β’ Author and review clinical pharmacology content for Investigational Brochures (IBs), clinical protocols, Clinical Study Reports (CSRs), and regulatory submission documents. β’ Collaborate closely with Clinical Development, Translational Sciences, Regulatory Affairs, Biometrics, Biomarkers, Medical Affairs, and Program Leadership teams to support program strategy and execution. β’ Present quantitative analyses, development strategies, and recommendations to project teams and senior leadership. β’ Maintain current knowledge of evolving scientific methodologies, regulatory guidance, and industry trends related to pharmacometrics, clinical pharmacology, and RNAi therapeutics.
β’ PhD or equivalent advanced degree in Pharmacokinetics, Pharmacology, Pharmaceutical Sciences, Biomedical Engineering, Applied Mathematics, or related quantitative discipline. β’ 12+ years in pharmacometrics and/or clinical pharmacology, including experience supporting late-stage development programs and global regulatory submissions. β’ Deep expertise in population PK/PD modeling and simulation with strong proficiency in industry-standard software such as NONMEM. β’ Strong understanding of exposure-response analysis, translational modeling, dose optimization, and model-informed drug development principles. β’ Experience supporting regulatory interactions with FDA, EMA, and other global health authorities. β’ Knowledge of PBPK, QSP, mechanistic modeling, or systems pharmacology approaches is highly desirable. β’ Prior experience with oligonucleotide, RNAi, rare disease, liver-targeted therapeutics, or other complex biologic modalities is preferred. β’ Demonstrated ability to independently lead complex scientific initiatives and influence cross-functional teams in a matrixed environment. β’ Excellent communication and presentation skills, with the ability to clearly communicate complex quantitative concepts to scientific and non-scientific audiences. β’ Familiarity with PBPK/PD or quantitative systems pharmacology (QSP) modeling.
β’ Competitive salaries β’ Excellent benefit package
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π October 30
Global Alliance Director building GSI and MSP partnerships for Apiphani, a managed intelligence provider for complex SAP estates. Selling white-label SAP managed operations and application management services.
π October 30
Director leading project delivery, account portfolios, budgets, and agency workflows for Avalere Healthβs healthcare marketing business. Managing teams, clients, resources, and operational excellence across pharmaceutical campaigns.
πΊπΈ United States β Remote
π΅ $130k - $155k / year
β° Full Time
π΄ Lead
π Director
π¦ H1B Visa Sponsor
π October 30
Regional Medical Affairs Director leading six ophthalmology-focused MSLs for Tarsus Pharmaceuticals. Driving scientific engagement, KOL relationships, field strategy, and medical operations across the East region.
π October 30
Executive Director leading global Medical Affairs strategy, operations, teams, and P&L. EVERSANA delivers commercialization services for life sciences and biopharmaceutical companies.
π October 30
Executive Director leading strategy, operations, finances, and sponsorships for member associations at AMR Management Services. Partnering with Boards and volunteers in a remote-first environment.